Supercharge Your LNP Product Quality to Expedite Novel Treatments to Patients | Embrace Technology Innovations to Optimize LNP Formulation, Stability and Process Control to Achieve Seamless Scale-Up, Compliance and Cost Effectiveness

With the global nanopharmaceutical drug market poised to reach $82.7 billion by 2027, there has been no better time to invest in accelerating the development of truly curative LNP therapeutics.

The highly anticipated inaugural, industry focused, LNP Formulation and Process Development Summit will share the field's latest breakthroughs in LNP formulation and cutting-edge process development to enhance your pipeline progression.

As the demand for novel LNPs to support the delivery of nucleic acid-based therapies and oligonucleotides grows at an exponential rate, the key challenges associated with enhancing stability, efficacy and scalability need to be addressed. Can novel technology innovations be applied to optimize LNP formulation and achieve a seamless scale-up?

This summit will unite thought leaders from large pharma, fast-growing biotech and research institutes to improve their LNP product quality, discuss their challenges and shape future directions. Join 80+ senior leaders in this field to discuss novel techniques to optimize your LNPs, exploit process and manufacturing platforms for alternative therapeutics, and form insightful partnerships for large scale production.

With expert insights from Pfizer, Moderna, Ultragenyx and Sanofi, this is your must-attend meeting of 2022 to accelerate the development of your LNPs to expedite novel treatments to patients.

URLs:
Tickets: https://go.evvnt.com/957018-0?pid=1052
Brochure: https://go.evvnt.com/957018-3?pid=1052